
    
      The study is being conducted in the United States. It consists of 3 segments:

        -  Segment A: 2 to 21 day screening period

        -  Segment B: 8-week double-blind treatment period

        -  Segment C: 1-week follow-up period

      Subjects will have a polysomnography in a sleep lab two times during the study (at baseline
      and between visit 4-5) and also be required to wear an actigraphy monitoring tool. There will
      be several questionnaires completed throughout the study: CGI-child, CGI-parent/legal
      guardian, ADHD Rating Scale-IV, and the Pediatric Daytime Sleepiness Scale.
    
  